Literature DB >> 21107770

Estimation of cardiac left ventricular ejection fraction in transfusional cardiac iron overload by R2* magnetic resonance.

Juri Sakuta1, Yoshikazu Ito, Yukihiko Kimura, Jinho Park, Koichi Tokuuye, Kazuma Ohyashiki.   

Abstract

Cardiac dysfunction due to transfusional iron overload is one of the most critical complications for patients with transfusion-dependent hematological disorders. Clinical parameters such as total red blood cell (RBC) transfusion units and serum ferritin level are usually considered as indicators for initiation of iron chelation therapy. We used MRI-T2*, MRI-R2* values, and left ventricular ejection fraction in 19 adult patients with blood transfusion-dependent hematological disorders without consecutive oral iron chelation therapy, and propose possible formulae of cardiac function using known parameters, such as total RBC transfusion units and serum ferritin levels. We found a positive correlation in all patients between both R2* values (reciprocal values of T2*) and serum ferritin levels (r = 0.81) and also total RBC transfusion volume (r = 0.90), but not when we analyzed subgroups of patients whose T2* values were over 30 ms (0.52). From the formulae of the R2*, we concluded that approximately 50 Japanese units or 2,900 pmol/L ferritin might be the cutoff value indicating possible future cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107770     DOI: 10.1007/s12185-010-0719-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  13 in total

1.  Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool.

Authors:  Peter D Jensen; Finn T Jensen; Thorkil Christensen; Hans Eiskjaer; Ulrik Baandrup; Johan L Nielsen
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

2.  R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients.

Authors:  Efthymia Alexopoulou; Fotini Stripeli; Panagiotis Baras; Ioannis Seimenis; Antonis Kattamis; Vasilis Ladis; Efstathios Efstathopoulos; Elias N Brountzos; Alexis D Kelekis; Nikolaos L Kelekis
Journal:  J Magn Reson Imaging       Date:  2006-02       Impact factor: 4.813

3.  Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload.

Authors:  Toru Kiguchi; Yoshikazu Ito; Yukihiko Kimura; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2009-04-14       Impact factor: 2.490

Review 4.  Pathophysiology of iron overload.

Authors:  C Hershko; G Link; I Cabantchik
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

5.  Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis.

Authors:  George Shashaty; Raymond Frankewich; Tamal Chakraborti; Jasti Choudary; Suliman Al-Fayoumi; Alice Kacuba; Sonia Castillo; Kathy Robie-Suh; Dwaine Rieves; Karen Weiss; Richard Pazdur
Journal:  Oncology (Williston Park)       Date:  2006-12       Impact factor: 2.990

6.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

7.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Authors:  G M Felker; R E Thompson; J M Hare; R H Hruban; D E Clemetson; D L Howard; K L Baughman; E K Kasper
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

8.  Non-invasive assessment of hepatic iron stores by MRI.

Authors:  Y Gandon; D Olivié; D Guyader; C Aubé; F Oberti; V Sebille; Y Deugnier
Journal:  Lancet       Date:  2004-01-31       Impact factor: 79.321

9.  Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.

Authors:  Masaaki Takatoku; Takashi Uchiyama; Shinichiro Okamoto; Yuzuru Kanakura; Kenichi Sawada; Masao Tomonaga; Shinji Nakao; Tatsutoshi Nakahata; Mine Harada; Takashi Murate; Keiya Ozawa
Journal:  Eur J Haematol       Date:  2007-03-28       Impact factor: 2.997

10.  Evaluation of cardiac iron overload in transfusion-dependent adult marrow failure patients by magnetic resonance imaging.

Authors:  Jinho Park; Kazuma Ohyashiki; Soichi Akata; Kenichi Takara; Ritsuko Uno; Dai Kakizaki; Keisuke Miyazawa; Yukihiko Kimura; Koichi Tokuuye
Journal:  Leuk Res       Date:  2008-11-26       Impact factor: 3.156

View more
  1 in total

1.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.